The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women

Wiley, Teresa S.; Haraldsen, Jason T.

doi:10.1063/1.3699052

Title: The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women

Authors:

Wiley, Teresa S. ^[1]; Haraldsen, Jason T. ^[2]

Wiley Systems, Santa Fe, New Mexico 87505, USA
Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA, Center for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA

Publication Date:: Thu Mar 29 00:00:00 EDT 2012

Sponsoring Org.:: USDOE

OSTI Identifier:: 1198166

Grant/Contract Number:: AC52-06NA25396

Resource Type:: Published Article

Journal Name:: AIP Advances

Additional Journal Information:: Journal Name: AIP Advances Journal Volume: 2 Journal Issue: 1; Journal ID: ISSN 2158-3226

Publisher:: American Institute of Physics

Country of Publication:: United States

Language:: English

Citation Formats


                    Wiley, Teresa S., and Haraldsen, Jason T. The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women.  United States: N. p., 2012. 
Web.  doi:10.1063/1.3699052.

Copy to clipboard


                    Wiley, Teresa S., & Haraldsen, Jason T. The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women.  United States.  https://doi.org/10.1063/1.3699052

Copy to clipboard


                    Wiley, Teresa S., and Haraldsen, Jason T. Thu .  
"The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women".  United States.  https://doi.org/10.1063/1.3699052.

Copy to clipboard


                    
@article{osti_1198166,

  title        = {The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women},

  author       = {Wiley, Teresa S. and Haraldsen, Jason T.},

  abstractNote = {},

  doi          = {10.1063/1.3699052},

  journal      = {AIP Advances},

  number       = 1,

  volume       = 2,

  place        = {United States},

  year         = {Thu Mar 29 00:00:00 EDT 2012},

  month        = {Thu Mar 29 00:00:00 EDT 2012}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1063/1.3699052

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 1 work

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
journal, January 2000

Schairer, Catherine
JAMA, Vol. 283, Issue 4
DOI: 10.1001/jama.283.4.485

Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy
journal, June 1999

Santen, Richard J.; Petroni, Gina R.
The Journal of Clinical Endocrinology & Metabolism, Vol. 84, Issue 6, p. 1875-1881
DOI: 10.1210/jc.84.6.1875

Age at Onset as an Indicator of Familial risk of Breast Cancer
journal, June 1990

Claus, Elizabeth B.; Risch, Neil J.; Thompson, W. Douglas
American Journal of Epidemiology, Vol. 131, Issue 6
DOI: 10.1093/oxfordjournals.aje.a115616

The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines
journal, December 2003

Gauduchon, Juliette; Gouilleux, Fabrice; Maillard, SÉBastien
Annals of the New York Academy of Sciences, Vol. 1010, Issue 1
DOI: 10.1196/annals.1299.057

Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay
journal, November 1996

Norjavaara, E.
Journal of Clinical Endocrinology & Metabolism, Vol. 81, Issue 11
DOI: 10.1210/jc.81.11.4095

Possible relationship between menopause and age at onset of breast cancer
journal, January 1950

Anderson, Elving; Reed, Sheldon C.; Huseby, Robert A.
Cancer, Vol. 3, Issue 3
DOI: 10.1002/1097-0142(1950)3:3<410::AID-CNCR2820030303>3.0.CO;2-H

A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
journal, February 1992

London, Stephanie J.
JAMA: The Journal of the American Medical Association, Vol. 267, Issue 7
DOI: 10.1001/jama.1992.03480070057030

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology
journal, November 2000

Katzenellenbogen, Benita S.; Choi, Inho; Delage-Mourroux, Regis
The Journal of Steroid Biochemistry and Molecular Biology, Vol. 74, Issue 5
DOI: 10.1016/S0960-0760(00)00104-7

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
journal, November 2009

Fredholm, Hanna; Eaker, Sonja; Frisell, Jan
PLoS ONE, Vol. 4, Issue 11
DOI: 10.1371/journal.pone.0007695

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?
journal, January 2003

Mandelblatt, Jeanne; Figueiredo, Melissa; Cullen, Jennifer
Health and Quality of Life Outcomes, Vol. 1, Issue 1, p. 45
DOI: 10.1186/1477-7525-1-45

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study
journal, March 1993

Wiklund, Ingela; Karlberg, Johan; Mattsson, Lars-Åke
American Journal of Obstetrics and Gynecology, Vol. 168, Issue 3
DOI: 10.1016/S0002-9378(12)90828-5

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
journal, February 2009

Chlebowski, Rowan T.; Kuller, Lewis H.; Prentice, Ross L.
New England Journal of Medicine, Vol. 360, Issue 6
DOI: 10.1056/NEJMoa0807684

Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice
journal, June 2001

Conneely, Orla M.; Mulac-Jericevic, Biserka; Lydon, John P.
Molecular and Cellular Endocrinology, Vol. 179, Issue 1-2
DOI: 10.1016/S0303-7207(01)00465-8

A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.
journal, May 1992

Meyer, M. E.; Quirin-Stricker, C.; Lerouge, T.
Journal of Biological Chemistry, Vol. 267, Issue 15
DOI: 10.1016/S0021-9258(19)50100-4

Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis
journal, January 1999

Formby, B.; Wiley, T. S.
Molecular and Cellular Biochemistry, Vol. 202, Issue 1/2, p. 53-61
DOI: 10.1023/A:1007081021483

Morphological Changes in Breast Tissue with Menstrual Cycle
journal, December 2002

Ramakrishnan, Rathi; Khan, Seema A.; Badve, Sunil
Modern Pathology, Vol. 15, Issue 12
DOI: 10.1097/01.MP.0000039566.20817.46

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
journal, May 2008

Flesch-Janys, Dieter; Slanger, Tracy; Mutschelknauss, Elke
International Journal of Cancer, Vol. 123, Issue 4
DOI: 10.1002/ijc.23655

Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells
journal, August 2003

Takahashi, K.; Ohmichi, M.; Yoshida, M.
Journal of Endocrinology, Vol. 178, Issue 2
DOI: 10.1677/joe.0.1780319

Misrepresentations about palliative options and prognosis in motor neurone disease: some legal considerations
journal, February 2005

Foster, Charles
Journal of Evaluation in Clinical Practice, Vol. 11, Issue 1
DOI: 10.1111/j.1365-2753.2004.00487.x

Physiological Action of Progesterone in Target Tissues
journal, August 1997

Graham, J. D.
Endocrine Reviews, Vol. 18, Issue 4
DOI: 10.1210/er.18.4.502

Benign Breast Diseases: Classification, Diagnosis, and Management
journal, May 2006

Guray, Merih; Sahin, Aysegul A.
The Oncologist, Vol. 11, Issue 5
DOI: 10.1634/theoncologist.11-5-435

The roles of sex steroid receptor coregulators in cancer
journal, January 2002

Gao, Xiuhua; Loggie, Brian W.; Nawaz, Zafar
Molecular Cancer, Vol. 1, Issue 1, p. 7
DOI: 10.1186/1476-4598-1-7

The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG)
journal, February 2001

Fazzari, A.; Catalano, M. G.; Comba, A.
Molecular and Cellular Endocrinology, Vol. 172, Issue 1-2
DOI: 10.1016/S0303-7207(00)00397-X

Differential SERM Effects on Corepressor Binding Dictate ERα Activity in Vivo
journal, December 2002

Webb, Paul; Nguyen, Phuong; Kushner, Peter J.
Journal of Biological Chemistry, Vol. 278, Issue 9
DOI: 10.1074/jbc.M208501200

Estrogen Receptor ( ESR1 ) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
journal, November 2011

Kim, Chungyeul; Tang, Gong; Pogue-Geile, Katherine L.
Journal of Clinical Oncology, Vol. 29, Issue 31
DOI: 10.1200/JCO.2010.32.9615

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
journal, November 1998

Goldhirsch, A.; Glick, J. H.; Gelber, R. D.
JNCI Journal of the National Cancer Institute, Vol. 90, Issue 21
DOI: 10.1093/jnci/90.21.1601

Estrogen as therapy for breast cancer
journal, August 2002

Ingle, James N.
Breast Cancer Research, Vol. 4, Issue 4
DOI: 10.1186/bcr436

The significance of glucocorticoid pulsatility
journal, April 2008

Lightman, Stafford L.; Wiles, Crispin C.; Atkinson, Helen C.
European Journal of Pharmacology, Vol. 583, Issue 2-3
DOI: 10.1016/j.ejphar.2007.11.073

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.
journal, May 1990

Kastner, P.; Krust, A.; Turcotte, B.
The EMBO Journal, Vol. 9, Issue 5
DOI: 10.1002/j.1460-2075.1990.tb08280.x

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
journal, December 1994

Wen, D. X.; Xu, Y. F.; Mais, D. E.
Molecular and Cellular Biology, Vol. 14, Issue 12
DOI: 10.1128/MCB.14.12.8356

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
journal, September 2005

Goss, Paul E.; Ingle, James N.; Martino, Silvana
JNCI: Journal of the National Cancer Institute, Vol. 97, Issue 17
DOI: 10.1093/jnci/dji250

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
journal, December 2010

Cuzick, Jack; Sestak, Ivana; Baum, Michael
The Lancet Oncology, Vol. 11, Issue 12
DOI: 10.1016/S1470-2045(10)70257-6

Similar Records in DOE PAGES and OSTI.GOV collections:

Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor–Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative

Journal Article Wright, Jean L., E-mail: jwrigh71@jhmi.edu ; Parekh, Arti ; Pollock, Yao Yao ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To develop a multidisciplinary algorithmic approach to management of women aged ≥70 years with clinically staged T1N0 hormone receptor–positive breast cancer, including geriatric assessments predicting life expectancy and the likelihood of functional decline in the near future, in the context of a program-wide quality improvement initiative, to better select patients for therapeutic interventions. Methods and Materials: Two geriatric assessment tools, the Combined Lee-Schonberg Index and the Vulnerable Elderly Scale, were introduced into our clinical workflow to predict long-term mortality and likelihood of functional decline. Scores from these tools, along with patient preferences and clinical features, were incorporated into a preoperative algorithmmore »« less
https://doi.org/10.1016/J.IJROBP.2017.01.210
Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model

Journal Article Duursen, Majorie B.M. van, E-mail: M.vanDuursen@uu.nl ; Smeets, Evelien E.J.W. ; Rijk, Jeroen C.W. ; ... - Toxicology and Applied Pharmacology

Breast cancer treatment by the aromatase inhibitor Letrozole (LET) or Selective Estrogen Receptor Modulator Tamoxifen (TAM) can result in the onset of menopausal symptoms. Women often try to relieve these symptoms by taking menopausal supplements containing high levels of phytoestrogens. However, little is known about the potential interaction between these supplements and breast cancer treatment, especially aromatase inhibitors. In this study, interaction of phytoestrogens with the estrogen receptor alpha and TAM action was determined in an ER-reporter gene assay (BG1Luc4E2 cells) and human breast epithelial tumor cells (MCF-7). Potential interactions with aromatase activity and LET were determined in human adrenocorticocarcinomamore »« less
https://doi.org/10.1016/J.TAAP.2013.03.014
RESULTS OF HORMONE TREATMENT OF BREAST CANCER, WITH SPECIAL ATTENTION TO PROPHYLACTIC THERAPY. (in German)

Journal Article Schmidt, H ; Bauer, R - Strahlentherapie, 136: 259-62(Sept. 1968).
Five-year Results of Whole Breast Intensity Modulated Radiation Therapy for the Treatment of Early Stage Breast Cancer: The Fox Chase Cancer Center Experience

Journal Article Keller, Lanea M.M., E-mail: Lanea.Keller@fccc.edu ; Sopka, Dennis M. ; Tianyu, Li ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To report the 5-year outcomes using whole-breast intensity-modulated radiation therapy (IMRT) for the treatment of early-stage-breast cancer at the Fox Chase Cancer Center. Methods and Materials: A total of 946 women with early-stage breast cancer (stage 0, I, or II) were treated with IMRT after surgery with or without systemic therapy from 2003-2010. Whole-breast radiation was delivered via an IMRT technique with a median whole-breast radiation dose of 46 Gy and median tumor bed boost of 14 Gy. Endpoints included local-regional recurrence, cosmesis, and late complications. Results: With a median follow-up of 31 months (range, 1-97 months), there weremore »« less
https://doi.org/10.1016/J.IJROBP.2012.01.069
SU-E-T-79: A Study of the Effect of Clinical Tumor Volume Displacement On the Dosage of Post Modified Radical Mastectomy Intensity-Modulated Radiation Therapy Plans for Left-Sided Breast Cancer

Journal Article Zhang, W ; Ma, C ; Li, D ; ... - Medical Physics

Purpose: To explore the effect of clinical tumor volume (CTV) displacement on the dosage of intensity-modulated radiation therapy (IMRT) plans for left-sided breast cancer after modified radical mastectomy. Methods: We created 2 sets of IMRT plans based on PTV0.5 and PTV0.7 (with CTV displacement of 0.5cm and 0.7cm respectively) for each of the ten consecutive left-sided breast cancer patients after modified radical mastectomy, and compared the difference in PTV coverage and organ at risk (OAR) sparing between the two groups. And then, we compared the difference in PTV coverage in IMRT plans based on PTV0.5 between the group with properlymore »« less
https://doi.org/10.1118/1.4924440

Similar Records

Title: The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women

Citation Formats

Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk journal, January 2000

Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy journal, June 1999

Age at Onset as an Indicator of Familial risk of Breast Cancer journal, June 1990

The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines journal, December 2003

Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay journal, November 1996

Possible relationship between menopause and age at onset of breast cancer journal, January 1950

A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer journal, February 1992

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology journal, November 2000

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment journal, November 2009

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? journal, January 2003

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study journal, March 1993

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women journal, February 2009

Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice journal, June 2001

A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. journal, May 1992

Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis journal, January 1999

Morphological Changes in Breast Tissue with Menstrual Cycle journal, December 2002

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy journal, May 2008

Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells journal, August 2003

Misrepresentations about palliative options and prognosis in motor neurone disease: some legal considerations journal, February 2005

Physiological Action of Progesterone in Target Tissues journal, August 1997

Benign Breast Diseases: Classification, Diagnosis, and Management journal, May 2006

The roles of sex steroid receptor coregulators in cancer journal, January 2002

The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG) journal, February 2001

Differential SERM Effects on Corepressor Binding Dictate ERα Activity in Vivo journal, December 2002

Estrogen Receptor ( ESR1 ) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer journal, November 2011

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer journal, November 1998

Estrogen as therapy for breast cancer journal, August 2002

The significance of glucocorticoid pulsatility journal, April 2008

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. journal, May 1990

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. journal, December 1994

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 journal, September 2005

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial journal, December 2010

Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
journal, January 2000

Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy
journal, June 1999

Age at Onset as an Indicator of Familial risk of Breast Cancer
journal, June 1990

The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines
journal, December 2003

Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay
journal, November 1996

Possible relationship between menopause and age at onset of breast cancer
journal, January 1950

A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
journal, February 1992

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology
journal, November 2000

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
journal, November 2009

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?
journal, January 2003

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study
journal, March 1993

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
journal, February 2009

Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice
journal, June 2001

A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.
journal, May 1992

Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis
journal, January 1999

Morphological Changes in Breast Tissue with Menstrual Cycle
journal, December 2002

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
journal, May 2008

Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells
journal, August 2003

Misrepresentations about palliative options and prognosis in motor neurone disease: some legal considerations
journal, February 2005

Physiological Action of Progesterone in Target Tissues
journal, August 1997

Benign Breast Diseases: Classification, Diagnosis, and Management
journal, May 2006

The roles of sex steroid receptor coregulators in cancer
journal, January 2002

The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG)
journal, February 2001

Differential SERM Effects on Corepressor Binding Dictate ERα Activity in Vivo
journal, December 2002

Estrogen Receptor ( ESR1 ) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
journal, November 2011

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
journal, November 1998

Estrogen as therapy for breast cancer
journal, August 2002

The significance of glucocorticoid pulsatility
journal, April 2008

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.
journal, May 1990

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
journal, December 1994

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
journal, September 2005

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
journal, December 2010